Skip to content
DataLookout
Menu

NCT07944105

SPARK UPS/MFS: Study Of BET Inhibition With ZEN003694 To Potentiate Anti-Tumor Responses With Radiotherapy To Kickstart Abscopal Effect In Metastatic Undifferentiated Pleomorphic Sarcoma (UPS) And Myxofibrosarcoma (MFS).

StatusNot Yet Recruiting
PhasePhase 1/2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Safety and Adverse Events (AEs)
Timeframe: Through study completion; an average of 1 year

Arms and interventions

Phase 1 Dose Escalation: Treatment with ZEN003694 + RTExperimental
Phase 2 Randomized Expansion Arm A: Treatment with ZEN003694 + RTExperimental
Phase 2 Randomized Expansion Arm B: ObservationExperimental
Phase 2 Randomized Expansion Arm C: Treatment with ZEN003694 AloneExperimental

Drugs: ZEN003694, Radiation Therapy

Sites

1 site in 1 country

  • UT MD AndersonHouston, Texas, United States